7+ hour, 40+ min ago  (435+ words) Senju Pharma has launched a new drug for dry eye disease (DED) in Japan, Avarept, which is the first drug in the TRPV1 antagonist class to reach the market. Licensed from fellow Japanese drugmaker Mochida, Avarept (motugivatrep) ophthalmic suspension has been…...

10+ mon, 6+ day ago  (487+ words) A long-acting medicine developed by Novo Nordisk has been recommended as a treatment option for young people with growth hormone deficiency, a condition diagnosed in up to 500 children a year. Sogroya (somapacitan), which can be administered as a once-weekly subcutaneous…...